HEADER HYDROLASE 18-MAY-07 2Q05 TITLE CRYSTAL STRUCTURE OF TYR/SER PROTEIN PHOSPHATASE FROM VACCINIA VIRUS TITLE 2 WR COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN PHOSPHATASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: LATE PROTEIN H1; COMPND 5 EC: 3.1.3.48, 3.1.3.16; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: VACCINIA VIRUS WR; SOURCE 3 ORGANISM_TAXID: 10254; SOURCE 4 STRAIN: WR (WESTERN RESERVE), VACV; SOURCE 5 GENE: H1L, VACWR099; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS PHOSPHATASE, VACCINIA VIRUS, STRUCTURAL GENOMICS, APC7320, PSI-2, KEYWDS 2 PROTEIN STRUCTURE INITIATIVE, MIDWEST CENTER FOR STRUCTURAL KEYWDS 3 GENOMICS, MCSG, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.OSIPIUK,T.SKARINA,O.KAGAN,A.SAVCHENKO,A.EDWARDS,A.JOACHIMIAK, AUTHOR 2 MIDWEST CENTER FOR STRUCTURAL GENOMICS (MCSG) REVDAT 3 13-JUL-11 2Q05 1 VERSN REVDAT 2 24-FEB-09 2Q05 1 VERSN REVDAT 1 19-JUN-07 2Q05 0 JRNL AUTH J.OSIPIUK,T.SKARINA,O.KAGAN,A.SAVCHENKO,A.EDWARDS, JRNL AUTH 2 A.JOACHIMIAK JRNL TITL CRYSTAL STRUCTURE OF TYR/SER PROTEIN PHOSPHATASE FROM JRNL TITL 2 VACCINIA VIRUS WR. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.57 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.57 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 48741 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2610 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.57 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.64 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3490 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.93 REMARK 3 BIN R VALUE (WORKING SET) : 0.3280 REMARK 3 BIN FREE R VALUE SET COUNT : 170 REMARK 3 BIN FREE R VALUE : 0.3470 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5738 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 63 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 65.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.96 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.240 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.198 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.137 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 13.217 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5887 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7951 ; 1.523 ; 1.966 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 715 ; 5.811 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 262 ;38.168 ;23.779 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1081 ;19.445 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 32 ;19.885 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 888 ; 0.110 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4361 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2561 ; 0.226 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4003 ; 0.321 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 216 ; 0.129 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 74 ; 0.263 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.091 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3657 ; 0.982 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5806 ; 1.484 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2514 ; 2.309 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2141 ; 3.320 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. ONLY FRAGMENTS OF N-TERMINAL PARTS (HIS-TAGS) OF REMARK 3 CHAINS A AND D WERE IDENTIFIED IN THE ELECTRON DENSITY AND REMARK 3 MODELED WITH THE SIDE CHAIN ATOMS MISSING. REMARK 4 REMARK 4 2Q05 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-MAY-07. REMARK 100 THE RCSB ID CODE IS RCSB042982. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-MAR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51445 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.570 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 22.500 REMARK 200 R MERGE (I) : 0.13300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 35.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.57 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : 8.80 REMARK 200 R MERGE FOR SHELL (I) : 0.89900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.210 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHELXD, MLPHARE, DM, SOLVE/RESOLVE, ARP/WARP, HKL- REMARK 200 3000 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 72.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2M SODIUM ACETATE PH 7.0, B-PROPANE REMARK 280 BUFFER PH 6.8, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 Z,X,Y REMARK 290 6555 Z+1/2,-X+1/2,-Y REMARK 290 7555 -Z+1/2,-X,Y+1/2 REMARK 290 8555 -Z,X+1/2,-Y+1/2 REMARK 290 9555 Y,Z,X REMARK 290 10555 -Y,Z+1/2,-X+1/2 REMARK 290 11555 Y+1/2,-Z+1/2,-X REMARK 290 12555 -Y+1/2,-Z,X+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 84.62300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 84.62300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 84.62300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 84.62300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 84.62300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 84.62300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY2 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY1 6 0.000000 0.000000 1.000000 84.62300 REMARK 290 SMTRY2 6 -1.000000 0.000000 0.000000 84.62300 REMARK 290 SMTRY3 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 0.000000 -1.000000 84.62300 REMARK 290 SMTRY2 7 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 1.000000 0.000000 84.62300 REMARK 290 SMTRY1 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY2 8 1.000000 0.000000 0.000000 84.62300 REMARK 290 SMTRY3 8 0.000000 -1.000000 0.000000 84.62300 REMARK 290 SMTRY1 9 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 9 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY3 9 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 0.000000 1.000000 84.62300 REMARK 290 SMTRY3 10 -1.000000 0.000000 0.000000 84.62300 REMARK 290 SMTRY1 11 0.000000 1.000000 0.000000 84.62300 REMARK 290 SMTRY2 11 0.000000 0.000000 -1.000000 84.62300 REMARK 290 SMTRY3 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 12 0.000000 -1.000000 0.000000 84.62300 REMARK 290 SMTRY2 12 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY3 12 1.000000 0.000000 0.000000 84.62300 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 4 CHAIN(S). AUTHORS STATE THAT THE REMARK 300 BIOLOGICAL UNIT OF THIS PROTEIN IS EXPERIMENTALLY UNKNOWN. REMARK 300 THE DODECAMERIC ASSEMBLY OF THE BIOLOGICAL UNIT, SHOWN IN REMARK 300 REMARK 350, IS PREDICTED BY THE ANALYSIS OF PROTEIN REMARK 300 INTERFACES (PISA) BASED ON THIS CRYSTAL STRUCTURE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DODECAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DODECAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 31360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 84500 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -215.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 0.000000 -1.000000 169.24600 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 -84.62300 REMARK 350 BIOMT3 2 0.000000 -1.000000 0.000000 84.62300 REMARK 350 BIOMT1 3 0.000000 1.000000 0.000000 84.62300 REMARK 350 BIOMT2 3 0.000000 0.000000 -1.000000 84.62300 REMARK 350 BIOMT3 3 -1.000000 0.000000 0.000000 169.24600 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A -21 REMARK 465 GLY A -20 REMARK 465 SER A -19 REMARK 465 SER A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 ARG A -8 REMARK 465 GLU A -7 REMARK 465 ASN A -6 REMARK 465 LEU A -5 REMARK 465 LYS A 170 REMARK 465 ASN A 171 REMARK 465 GLY A 172 REMARK 465 SER A 173 REMARK 465 MSE B -21 REMARK 465 GLY B -20 REMARK 465 SER B -19 REMARK 465 SER B -18 REMARK 465 HIS B -17 REMARK 465 HIS B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 SER B -11 REMARK 465 SER B -10 REMARK 465 GLY B -9 REMARK 465 ARG B -8 REMARK 465 GLY B 172 REMARK 465 SER B 173 REMARK 465 MSE C -21 REMARK 465 GLY C -20 REMARK 465 SER C -19 REMARK 465 SER C -18 REMARK 465 HIS C -17 REMARK 465 HIS C -16 REMARK 465 HIS C -15 REMARK 465 HIS C -14 REMARK 465 HIS C -13 REMARK 465 HIS C -12 REMARK 465 SER C -11 REMARK 465 SER C -10 REMARK 465 GLY C -9 REMARK 465 ARG C -8 REMARK 465 GLU C -7 REMARK 465 ASN C -6 REMARK 465 LEU C -5 REMARK 465 TYR C -4 REMARK 465 PHE C -3 REMARK 465 GLN C -2 REMARK 465 ASN C 171 REMARK 465 GLY C 172 REMARK 465 SER C 173 REMARK 465 MSE D -21 REMARK 465 GLY D -20 REMARK 465 SER D -19 REMARK 465 SER D -18 REMARK 465 HIS D -17 REMARK 465 HIS D -16 REMARK 465 HIS D -15 REMARK 465 HIS D -14 REMARK 465 ASN D -6 REMARK 465 LEU D -5 REMARK 465 TYR D -4 REMARK 465 ASN D 171 REMARK 465 GLY D 172 REMARK 465 SER D 173 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A -15 ND1 CD2 CE1 NE2 REMARK 470 HIS A -14 ND1 CD2 CE1 NE2 REMARK 470 HIS A -13 ND1 CD2 CE1 NE2 REMARK 470 HIS A -12 ND1 CD2 CE1 NE2 REMARK 470 HIS D -13 ND1 CD2 CE1 NE2 REMARK 470 HIS D -12 ND1 CD2 CE1 NE2 REMARK 470 ARG D -8 CG CD NE CZ NH1 NH2 REMARK 470 GLU D -7 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLY A -9 C GLY A -9 O 0.154 REMARK 500 LYS A 3 CD LYS A 3 CE 0.292 REMARK 500 LYS A 3 CE LYS A 3 NZ 0.520 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS A 3 CD - CE - NZ ANGL. DEV. = -26.1 DEGREES REMARK 500 PRO A 134 C - N - CA ANGL. DEV. = 9.2 DEGREES REMARK 500 ARG B 149 NE - CZ - NH1 ANGL. DEV. = -4.0 DEGREES REMARK 500 ARG D 149 NE - CZ - NH1 ANGL. DEV. = -4.1 DEGREES REMARK 500 ARG D 149 NE - CZ - NH2 ANGL. DEV. = 3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A -11 -131.23 -152.30 REMARK 500 SER A -10 -103.37 -150.77 REMARK 500 PHE A -3 13.63 -65.19 REMARK 500 HIS A 0 -51.23 -159.57 REMARK 500 THR A 25 -55.32 -120.85 REMARK 500 PRO A 66 -96.80 -28.48 REMARK 500 ASN A 103 55.05 33.69 REMARK 500 CYS A 110 -151.07 -130.14 REMARK 500 ASN A 115 -68.97 -93.28 REMARK 500 VAL A 153 73.21 18.29 REMARK 500 ASN B -6 27.02 -156.96 REMARK 500 HIS B 0 -35.19 -153.65 REMARK 500 ASP B 17 67.90 -110.94 REMARK 500 THR B 25 -35.86 -130.56 REMARK 500 CYS B 110 -138.69 -120.40 REMARK 500 ASN B 115 -65.40 -96.28 REMARK 500 PRO B 134 63.22 -69.87 REMARK 500 VAL B 153 68.31 38.21 REMARK 500 ASN B 155 109.34 -59.47 REMARK 500 LYS B 170 -114.98 -135.23 REMARK 500 MSE C 1 -150.26 -105.94 REMARK 500 THR C 31 -163.56 -125.80 REMARK 500 CYS C 110 -142.64 -133.39 REMARK 500 ALA C 111 -70.24 -75.49 REMARK 500 ASN C 115 -68.92 -95.52 REMARK 500 VAL C 153 66.51 35.97 REMARK 500 ASP C 169 -79.80 -123.26 REMARK 500 ARG D -8 -43.30 -136.48 REMARK 500 GLN D -2 -14.48 -152.66 REMARK 500 HIS D 0 -17.80 -168.69 REMARK 500 ASP D 17 74.90 -102.05 REMARK 500 ASN D 67 68.10 -105.88 REMARK 500 CYS D 110 -143.29 -123.10 REMARK 500 VAL D 114 -59.57 -120.50 REMARK 500 ASN D 115 -60.30 -93.49 REMARK 500 PHE D 152 112.26 -160.28 REMARK 500 ASN D 155 107.95 -58.60 REMARK 500 ILE D 168 -74.15 -59.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY B -1 HIS B 0 -149.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 VAL B 167 23.9 L L OUTSIDE RANGE REMARK 500 ASP B 169 24.7 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: APC7320 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 AUTHORS STATE THAT THE ELECTRON DENSITY CLEARLY SHOWS THE REMARK 999 PRESENCE OF ARGININE AT SEQUENCE POSITION 20 IN ALL FOUR REMARK 999 CHAINS A-D IN THE ASYMMETRIC UNIT. THE PRESENCE OF REMARK 999 ARGININES IS SUPPORTED BY OMIT MAPS AND BY THE R-FACTOR REMARK 999 INCREASE WHEN LYSINES ARE BEING REFINED AT THAT POSITION. DBREF 2Q05 A 1 171 UNP P07239 DUSP_VACCV 1 171 DBREF 2Q05 B 1 171 UNP P07239 DUSP_VACCV 1 171 DBREF 2Q05 C 1 171 UNP P07239 DUSP_VACCV 1 171 DBREF 2Q05 D 1 171 UNP P07239 DUSP_VACCV 1 171 SEQADV 2Q05 MSE A -21 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLY A -20 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER A -19 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER A -18 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS A -17 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS A -16 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS A -15 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS A -14 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS A -13 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS A -12 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER A -11 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER A -10 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLY A -9 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 ARG A -8 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLU A -7 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 ASN A -6 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 LEU A -5 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 TYR A -4 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 PHE A -3 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLN A -2 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLY A -1 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS A 0 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 MSE A 1 UNP P07239 MET 1 MODIFIED RESIDUE SEQADV 2Q05 MSE A 18 UNP P07239 MET 18 MODIFIED RESIDUE SEQADV 2Q05 ARG A 20 UNP P07239 LYS 20 SEE REMARK 999 SEQADV 2Q05 MSE A 27 UNP P07239 MET 27 MODIFIED RESIDUE SEQADV 2Q05 MSE A 43 UNP P07239 MET 43 MODIFIED RESIDUE SEQADV 2Q05 MSE A 60 UNP P07239 MET 60 MODIFIED RESIDUE SEQADV 2Q05 MSE A 120 UNP P07239 MET 120 MODIFIED RESIDUE SEQADV 2Q05 MSE A 126 UNP P07239 MET 126 MODIFIED RESIDUE SEQADV 2Q05 MSE A 135 UNP P07239 MET 135 MODIFIED RESIDUE SEQADV 2Q05 MSE A 145 UNP P07239 MET 145 MODIFIED RESIDUE SEQADV 2Q05 GLY A 172 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER A 173 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 MSE B -21 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLY B -20 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER B -19 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER B -18 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS B -17 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS B -16 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS B -15 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS B -14 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS B -13 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS B -12 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER B -11 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER B -10 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLY B -9 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 ARG B -8 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLU B -7 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 ASN B -6 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 LEU B -5 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 TYR B -4 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 PHE B -3 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLN B -2 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLY B -1 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS B 0 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 MSE B 1 UNP P07239 MET 1 MODIFIED RESIDUE SEQADV 2Q05 MSE B 18 UNP P07239 MET 18 MODIFIED RESIDUE SEQADV 2Q05 ARG B 20 UNP P07239 LYS 20 SEE REMARK 999 SEQADV 2Q05 MSE B 27 UNP P07239 MET 27 MODIFIED RESIDUE SEQADV 2Q05 MSE B 43 UNP P07239 MET 43 MODIFIED RESIDUE SEQADV 2Q05 MSE B 60 UNP P07239 MET 60 MODIFIED RESIDUE SEQADV 2Q05 MSE B 120 UNP P07239 MET 120 MODIFIED RESIDUE SEQADV 2Q05 MSE B 126 UNP P07239 MET 126 MODIFIED RESIDUE SEQADV 2Q05 MSE B 135 UNP P07239 MET 135 MODIFIED RESIDUE SEQADV 2Q05 MSE B 145 UNP P07239 MET 145 MODIFIED RESIDUE SEQADV 2Q05 GLY B 172 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER B 173 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 MSE C -21 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLY C -20 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER C -19 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER C -18 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS C -17 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS C -16 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS C -15 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS C -14 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS C -13 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS C -12 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER C -11 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER C -10 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLY C -9 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 ARG C -8 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLU C -7 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 ASN C -6 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 LEU C -5 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 TYR C -4 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 PHE C -3 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLN C -2 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLY C -1 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS C 0 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 MSE C 1 UNP P07239 MET 1 MODIFIED RESIDUE SEQADV 2Q05 MSE C 18 UNP P07239 MET 18 MODIFIED RESIDUE SEQADV 2Q05 ARG C 20 UNP P07239 LYS 20 SEE REMARK 999 SEQADV 2Q05 MSE C 27 UNP P07239 MET 27 MODIFIED RESIDUE SEQADV 2Q05 MSE C 43 UNP P07239 MET 43 MODIFIED RESIDUE SEQADV 2Q05 MSE C 60 UNP P07239 MET 60 MODIFIED RESIDUE SEQADV 2Q05 MSE C 120 UNP P07239 MET 120 MODIFIED RESIDUE SEQADV 2Q05 MSE C 126 UNP P07239 MET 126 MODIFIED RESIDUE SEQADV 2Q05 MSE C 135 UNP P07239 MET 135 MODIFIED RESIDUE SEQADV 2Q05 MSE C 145 UNP P07239 MET 145 MODIFIED RESIDUE SEQADV 2Q05 GLY C 172 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER C 173 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 MSE D -21 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLY D -20 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER D -19 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER D -18 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS D -17 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS D -16 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS D -15 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS D -14 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS D -13 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS D -12 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER D -11 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER D -10 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLY D -9 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 ARG D -8 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLU D -7 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 ASN D -6 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 LEU D -5 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 TYR D -4 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 PHE D -3 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLN D -2 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 GLY D -1 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 HIS D 0 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 MSE D 1 UNP P07239 MET 1 MODIFIED RESIDUE SEQADV 2Q05 MSE D 18 UNP P07239 MET 18 MODIFIED RESIDUE SEQADV 2Q05 ARG D 20 UNP P07239 LYS 20 SEE REMARK 999 SEQADV 2Q05 MSE D 27 UNP P07239 MET 27 MODIFIED RESIDUE SEQADV 2Q05 MSE D 43 UNP P07239 MET 43 MODIFIED RESIDUE SEQADV 2Q05 MSE D 60 UNP P07239 MET 60 MODIFIED RESIDUE SEQADV 2Q05 MSE D 120 UNP P07239 MET 120 MODIFIED RESIDUE SEQADV 2Q05 MSE D 126 UNP P07239 MET 126 MODIFIED RESIDUE SEQADV 2Q05 MSE D 135 UNP P07239 MET 135 MODIFIED RESIDUE SEQADV 2Q05 MSE D 145 UNP P07239 MET 145 MODIFIED RESIDUE SEQADV 2Q05 GLY D 172 UNP P07239 CLONING ARTIFACT SEQADV 2Q05 SER D 173 UNP P07239 CLONING ARTIFACT SEQRES 1 A 195 MSE GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 195 ARG GLU ASN LEU TYR PHE GLN GLY HIS MSE ASP LYS LYS SEQRES 3 A 195 SER LEU TYR LYS TYR LEU LEU LEU ARG SER THR GLY ASP SEQRES 4 A 195 MSE HIS ARG ALA LYS SER PRO THR ILE MSE THR ARG VAL SEQRES 5 A 195 THR ASN ASN VAL TYR LEU GLY ASN TYR LYS ASN ALA MSE SEQRES 6 A 195 ASP ALA PRO SER SER GLU VAL LYS PHE LYS TYR VAL LEU SEQRES 7 A 195 ASN LEU THR MSE ASP LYS TYR THR LEU PRO ASN SER ASN SEQRES 8 A 195 ILE ASN ILE ILE HIS ILE PRO LEU VAL ASP ASP THR THR SEQRES 9 A 195 THR ASP ILE SER LYS TYR PHE ASP ASP VAL THR ALA PHE SEQRES 10 A 195 LEU SER LYS CYS ASP GLN ARG ASN GLU PRO VAL LEU VAL SEQRES 11 A 195 HIS CYS ALA ALA GLY VAL ASN ARG SER GLY ALA MSE ILE SEQRES 12 A 195 LEU ALA TYR LEU MSE SER LYS ASN LYS GLU SER LEU PRO SEQRES 13 A 195 MSE LEU TYR PHE LEU TYR VAL TYR HIS SER MSE ARG ASP SEQRES 14 A 195 LEU ARG GLY ALA PHE VAL GLU ASN PRO SER PHE LYS ARG SEQRES 15 A 195 GLN ILE ILE GLU LYS TYR VAL ILE ASP LYS ASN GLY SER SEQRES 1 B 195 MSE GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 195 ARG GLU ASN LEU TYR PHE GLN GLY HIS MSE ASP LYS LYS SEQRES 3 B 195 SER LEU TYR LYS TYR LEU LEU LEU ARG SER THR GLY ASP SEQRES 4 B 195 MSE HIS ARG ALA LYS SER PRO THR ILE MSE THR ARG VAL SEQRES 5 B 195 THR ASN ASN VAL TYR LEU GLY ASN TYR LYS ASN ALA MSE SEQRES 6 B 195 ASP ALA PRO SER SER GLU VAL LYS PHE LYS TYR VAL LEU SEQRES 7 B 195 ASN LEU THR MSE ASP LYS TYR THR LEU PRO ASN SER ASN SEQRES 8 B 195 ILE ASN ILE ILE HIS ILE PRO LEU VAL ASP ASP THR THR SEQRES 9 B 195 THR ASP ILE SER LYS TYR PHE ASP ASP VAL THR ALA PHE SEQRES 10 B 195 LEU SER LYS CYS ASP GLN ARG ASN GLU PRO VAL LEU VAL SEQRES 11 B 195 HIS CYS ALA ALA GLY VAL ASN ARG SER GLY ALA MSE ILE SEQRES 12 B 195 LEU ALA TYR LEU MSE SER LYS ASN LYS GLU SER LEU PRO SEQRES 13 B 195 MSE LEU TYR PHE LEU TYR VAL TYR HIS SER MSE ARG ASP SEQRES 14 B 195 LEU ARG GLY ALA PHE VAL GLU ASN PRO SER PHE LYS ARG SEQRES 15 B 195 GLN ILE ILE GLU LYS TYR VAL ILE ASP LYS ASN GLY SER SEQRES 1 C 195 MSE GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 C 195 ARG GLU ASN LEU TYR PHE GLN GLY HIS MSE ASP LYS LYS SEQRES 3 C 195 SER LEU TYR LYS TYR LEU LEU LEU ARG SER THR GLY ASP SEQRES 4 C 195 MSE HIS ARG ALA LYS SER PRO THR ILE MSE THR ARG VAL SEQRES 5 C 195 THR ASN ASN VAL TYR LEU GLY ASN TYR LYS ASN ALA MSE SEQRES 6 C 195 ASP ALA PRO SER SER GLU VAL LYS PHE LYS TYR VAL LEU SEQRES 7 C 195 ASN LEU THR MSE ASP LYS TYR THR LEU PRO ASN SER ASN SEQRES 8 C 195 ILE ASN ILE ILE HIS ILE PRO LEU VAL ASP ASP THR THR SEQRES 9 C 195 THR ASP ILE SER LYS TYR PHE ASP ASP VAL THR ALA PHE SEQRES 10 C 195 LEU SER LYS CYS ASP GLN ARG ASN GLU PRO VAL LEU VAL SEQRES 11 C 195 HIS CYS ALA ALA GLY VAL ASN ARG SER GLY ALA MSE ILE SEQRES 12 C 195 LEU ALA TYR LEU MSE SER LYS ASN LYS GLU SER LEU PRO SEQRES 13 C 195 MSE LEU TYR PHE LEU TYR VAL TYR HIS SER MSE ARG ASP SEQRES 14 C 195 LEU ARG GLY ALA PHE VAL GLU ASN PRO SER PHE LYS ARG SEQRES 15 C 195 GLN ILE ILE GLU LYS TYR VAL ILE ASP LYS ASN GLY SER SEQRES 1 D 195 MSE GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 D 195 ARG GLU ASN LEU TYR PHE GLN GLY HIS MSE ASP LYS LYS SEQRES 3 D 195 SER LEU TYR LYS TYR LEU LEU LEU ARG SER THR GLY ASP SEQRES 4 D 195 MSE HIS ARG ALA LYS SER PRO THR ILE MSE THR ARG VAL SEQRES 5 D 195 THR ASN ASN VAL TYR LEU GLY ASN TYR LYS ASN ALA MSE SEQRES 6 D 195 ASP ALA PRO SER SER GLU VAL LYS PHE LYS TYR VAL LEU SEQRES 7 D 195 ASN LEU THR MSE ASP LYS TYR THR LEU PRO ASN SER ASN SEQRES 8 D 195 ILE ASN ILE ILE HIS ILE PRO LEU VAL ASP ASP THR THR SEQRES 9 D 195 THR ASP ILE SER LYS TYR PHE ASP ASP VAL THR ALA PHE SEQRES 10 D 195 LEU SER LYS CYS ASP GLN ARG ASN GLU PRO VAL LEU VAL SEQRES 11 D 195 HIS CYS ALA ALA GLY VAL ASN ARG SER GLY ALA MSE ILE SEQRES 12 D 195 LEU ALA TYR LEU MSE SER LYS ASN LYS GLU SER LEU PRO SEQRES 13 D 195 MSE LEU TYR PHE LEU TYR VAL TYR HIS SER MSE ARG ASP SEQRES 14 D 195 LEU ARG GLY ALA PHE VAL GLU ASN PRO SER PHE LYS ARG SEQRES 15 D 195 GLN ILE ILE GLU LYS TYR VAL ILE ASP LYS ASN GLY SER MODRES 2Q05 MSE A 1 MET SELENOMETHIONINE MODRES 2Q05 MSE A 18 MET SELENOMETHIONINE MODRES 2Q05 MSE A 27 MET SELENOMETHIONINE MODRES 2Q05 MSE A 43 MET SELENOMETHIONINE MODRES 2Q05 MSE A 60 MET SELENOMETHIONINE MODRES 2Q05 MSE A 120 MET SELENOMETHIONINE MODRES 2Q05 MSE A 126 MET SELENOMETHIONINE MODRES 2Q05 MSE A 135 MET SELENOMETHIONINE MODRES 2Q05 MSE A 145 MET SELENOMETHIONINE MODRES 2Q05 MSE B 1 MET SELENOMETHIONINE MODRES 2Q05 MSE B 18 MET SELENOMETHIONINE MODRES 2Q05 MSE B 27 MET SELENOMETHIONINE MODRES 2Q05 MSE B 43 MET SELENOMETHIONINE MODRES 2Q05 MSE B 60 MET SELENOMETHIONINE MODRES 2Q05 MSE B 120 MET SELENOMETHIONINE MODRES 2Q05 MSE B 126 MET SELENOMETHIONINE MODRES 2Q05 MSE B 135 MET SELENOMETHIONINE MODRES 2Q05 MSE B 145 MET SELENOMETHIONINE MODRES 2Q05 MSE C 1 MET SELENOMETHIONINE MODRES 2Q05 MSE C 18 MET SELENOMETHIONINE MODRES 2Q05 MSE C 27 MET SELENOMETHIONINE MODRES 2Q05 MSE C 43 MET SELENOMETHIONINE MODRES 2Q05 MSE C 60 MET SELENOMETHIONINE MODRES 2Q05 MSE C 120 MET SELENOMETHIONINE MODRES 2Q05 MSE C 126 MET SELENOMETHIONINE MODRES 2Q05 MSE C 135 MET SELENOMETHIONINE MODRES 2Q05 MSE C 145 MET SELENOMETHIONINE MODRES 2Q05 MSE D 1 MET SELENOMETHIONINE MODRES 2Q05 MSE D 18 MET SELENOMETHIONINE MODRES 2Q05 MSE D 27 MET SELENOMETHIONINE MODRES 2Q05 MSE D 43 MET SELENOMETHIONINE MODRES 2Q05 MSE D 60 MET SELENOMETHIONINE MODRES 2Q05 MSE D 120 MET SELENOMETHIONINE MODRES 2Q05 MSE D 126 MET SELENOMETHIONINE MODRES 2Q05 MSE D 135 MET SELENOMETHIONINE MODRES 2Q05 MSE D 145 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 18 8 HET MSE A 27 8 HET MSE A 43 8 HET MSE A 60 8 HET MSE A 120 8 HET MSE A 126 8 HET MSE A 135 8 HET MSE A 145 8 HET MSE B 1 8 HET MSE B 18 8 HET MSE B 27 8 HET MSE B 43 8 HET MSE B 60 8 HET MSE B 120 8 HET MSE B 126 8 HET MSE B 135 8 HET MSE B 145 8 HET MSE C 1 8 HET MSE C 18 8 HET MSE C 27 8 HET MSE C 43 8 HET MSE C 60 8 HET MSE C 120 8 HET MSE C 126 8 HET MSE C 135 8 HET MSE C 145 8 HET MSE D 1 8 HET MSE D 18 8 HET MSE D 27 8 HET MSE D 43 8 HET MSE D 60 8 HET MSE D 120 8 HET MSE D 126 8 HET MSE D 135 13 HET MSE D 145 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 36(C5 H11 N O2 SE) FORMUL 5 HOH *63(H2 O) HELIX 1 1 ASP A 2 THR A 15 1 14 HELIX 2 2 ASN A 38 ALA A 45 1 8 HELIX 3 3 ILE A 85 LYS A 87 5 3 HELIX 4 4 TYR A 88 ARG A 102 1 15 HELIX 5 5 ASN A 115 ASN A 129 1 15 HELIX 6 6 LEU A 133 GLY A 150 1 18 HELIX 7 7 ASN A 155 VAL A 167 1 13 HELIX 8 8 ASN B -6 GLN B -2 5 5 HELIX 9 9 ASP B 2 THR B 15 1 14 HELIX 10 10 ASN B 38 ALA B 45 1 8 HELIX 11 11 ILE B 85 LYS B 87 5 3 HELIX 12 12 TYR B 88 ARG B 102 1 15 HELIX 13 13 ASN B 115 ASN B 129 1 15 HELIX 14 14 PRO B 134 GLY B 150 1 17 HELIX 15 15 ASN B 155 VAL B 167 1 13 HELIX 16 16 ASP C 2 THR C 15 1 14 HELIX 17 17 ASN C 38 ALA C 45 1 8 HELIX 18 18 PRO C 46 SER C 48 5 3 HELIX 19 19 ILE C 85 LYS C 87 5 3 HELIX 20 20 TYR C 88 ARG C 102 1 15 HELIX 21 21 ASN C 115 LYS C 128 1 14 HELIX 22 22 PRO C 134 GLY C 150 1 17 HELIX 23 23 ASN C 155 VAL C 167 1 13 HELIX 24 24 ASP D 2 SER D 14 1 13 HELIX 25 25 ASN D 38 ALA D 45 1 8 HELIX 26 26 PRO D 46 SER D 48 5 3 HELIX 27 27 ILE D 85 LYS D 87 5 3 HELIX 28 28 TYR D 88 ARG D 102 1 15 HELIX 29 29 ASN D 115 LYS D 128 1 14 HELIX 30 30 PRO D 134 GLY D 150 1 17 HELIX 31 31 ASN D 155 VAL D 167 1 13 SHEET 1 A 5 THR A 28 ARG A 29 0 SHEET 2 A 5 VAL A 34 GLY A 37 -1 O LEU A 36 N THR A 28 SHEET 3 A 5 VAL A 106 HIS A 109 1 O VAL A 108 N TYR A 35 SHEET 4 A 5 TYR A 54 ASN A 57 1 N LEU A 56 O LEU A 107 SHEET 5 A 5 ASN A 71 HIS A 74 1 O ILE A 73 N ASN A 57 SHEET 1 B 5 THR B 28 ARG B 29 0 SHEET 2 B 5 VAL B 34 GLY B 37 -1 O LEU B 36 N THR B 28 SHEET 3 B 5 VAL B 106 HIS B 109 1 O VAL B 108 N TYR B 35 SHEET 4 B 5 TYR B 54 ASN B 57 1 N LEU B 56 O LEU B 107 SHEET 5 B 5 ASN B 71 HIS B 74 1 O ILE B 73 N ASN B 57 SHEET 1 C 5 THR C 28 ARG C 29 0 SHEET 2 C 5 VAL C 34 GLY C 37 -1 O LEU C 36 N THR C 28 SHEET 3 C 5 VAL C 106 HIS C 109 1 O VAL C 106 N TYR C 35 SHEET 4 C 5 TYR C 54 ASN C 57 1 N LEU C 56 O LEU C 107 SHEET 5 C 5 ASN C 71 HIS C 74 1 O ILE C 73 N VAL C 55 SHEET 1 D 5 THR D 28 ARG D 29 0 SHEET 2 D 5 VAL D 34 GLY D 37 -1 O LEU D 36 N THR D 28 SHEET 3 D 5 VAL D 106 HIS D 109 1 O VAL D 108 N TYR D 35 SHEET 4 D 5 TYR D 54 ASN D 57 1 N LEU D 56 O LEU D 107 SHEET 5 D 5 ASN D 71 HIS D 74 1 O ILE D 73 N VAL D 55 LINK C HIS A 0 N MSE A 1 1555 1555 1.33 LINK C MSE A 1 N ASP A 2 1555 1555 1.33 LINK C ASP A 17 N MSE A 18 1555 1555 1.33 LINK C MSE A 18 N HIS A 19 1555 1555 1.31 LINK C ILE A 26 N MSE A 27 1555 1555 1.33 LINK C MSE A 27 N THR A 28 1555 1555 1.32 LINK C ALA A 42 N MSE A 43 1555 1555 1.33 LINK C MSE A 43 N ASP A 44 1555 1555 1.33 LINK C THR A 59 N MSE A 60 1555 1555 1.33 LINK C MSE A 60 N ASP A 61 1555 1555 1.33 LINK C ALA A 119 N MSE A 120 1555 1555 1.33 LINK C MSE A 120 N ILE A 121 1555 1555 1.34 LINK C LEU A 125 N MSE A 126 1555 1555 1.33 LINK C MSE A 126 N SER A 127 1555 1555 1.33 LINK C PRO A 134 N MSE A 135 1555 1555 1.32 LINK C MSE A 135 N LEU A 136 1555 1555 1.33 LINK C SER A 144 N MSE A 145 1555 1555 1.32 LINK C MSE A 145 N ARG A 146 1555 1555 1.33 LINK C HIS B 0 N MSE B 1 1555 1555 1.33 LINK C MSE B 1 N ASP B 2 1555 1555 1.33 LINK C ASP B 17 N MSE B 18 1555 1555 1.33 LINK C MSE B 18 N HIS B 19 1555 1555 1.32 LINK C ILE B 26 N MSE B 27 1555 1555 1.34 LINK C MSE B 27 N THR B 28 1555 1555 1.32 LINK C ALA B 42 N MSE B 43 1555 1555 1.33 LINK C MSE B 43 N ASP B 44 1555 1555 1.33 LINK C THR B 59 N MSE B 60 1555 1555 1.32 LINK C MSE B 60 N ASP B 61 1555 1555 1.32 LINK C ALA B 119 N MSE B 120 1555 1555 1.34 LINK C MSE B 120 N ILE B 121 1555 1555 1.34 LINK C LEU B 125 N MSE B 126 1555 1555 1.33 LINK C MSE B 126 N SER B 127 1555 1555 1.33 LINK C PRO B 134 N MSE B 135 1555 1555 1.33 LINK C MSE B 135 N LEU B 136 1555 1555 1.33 LINK C SER B 144 N MSE B 145 1555 1555 1.33 LINK C MSE B 145 N ARG B 146 1555 1555 1.33 LINK C HIS C 0 N MSE C 1 1555 1555 1.34 LINK C MSE C 1 N ASP C 2 1555 1555 1.34 LINK C ASP C 17 N MSE C 18 1555 1555 1.33 LINK C MSE C 18 N HIS C 19 1555 1555 1.32 LINK C ILE C 26 N MSE C 27 1555 1555 1.31 LINK C MSE C 27 N THR C 28 1555 1555 1.33 LINK C ALA C 42 N MSE C 43 1555 1555 1.33 LINK C MSE C 43 N ASP C 44 1555 1555 1.33 LINK C THR C 59 N MSE C 60 1555 1555 1.32 LINK C MSE C 60 N ASP C 61 1555 1555 1.33 LINK C ALA C 119 N MSE C 120 1555 1555 1.33 LINK C MSE C 120 N ILE C 121 1555 1555 1.33 LINK C LEU C 125 N MSE C 126 1555 1555 1.33 LINK C MSE C 126 N SER C 127 1555 1555 1.33 LINK C PRO C 134 N MSE C 135 1555 1555 1.32 LINK C MSE C 135 N LEU C 136 1555 1555 1.33 LINK C SER C 144 N MSE C 145 1555 1555 1.34 LINK C MSE C 145 N ARG C 146 1555 1555 1.34 LINK C HIS D 0 N MSE D 1 1555 1555 1.33 LINK C MSE D 1 N ASP D 2 1555 1555 1.33 LINK C ASP D 17 N MSE D 18 1555 1555 1.33 LINK C MSE D 18 N HIS D 19 1555 1555 1.33 LINK C ILE D 26 N MSE D 27 1555 1555 1.32 LINK C MSE D 27 N THR D 28 1555 1555 1.31 LINK C ALA D 42 N MSE D 43 1555 1555 1.33 LINK C MSE D 43 N ASP D 44 1555 1555 1.33 LINK C THR D 59 N MSE D 60 1555 1555 1.32 LINK C MSE D 60 N ASP D 61 1555 1555 1.32 LINK C ALA D 119 N MSE D 120 1555 1555 1.33 LINK C MSE D 120 N ILE D 121 1555 1555 1.34 LINK C LEU D 125 N MSE D 126 1555 1555 1.32 LINK C MSE D 126 N SER D 127 1555 1555 1.33 LINK C PRO D 134 N MSE D 135 1555 1555 1.33 LINK C MSE D 135 N LEU D 136 1555 1555 1.32 LINK C SER D 144 N MSE D 145 1555 1555 1.32 LINK C MSE D 145 N ARG D 146 1555 1555 1.33 CRYST1 169.246 169.246 169.246 90.00 90.00 90.00 P 21 3 48 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005909 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005909 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005909 0.00000